» Articles » PMID: 25893822

TTF-1-positive Oncocytic Sellar Tumor with Follicle Formation/ependymal Differentiation: Non-adenomatous Tumor Capable of Two Different Interpretations As a Pituicytoma or a Spindle Cell Oncocytoma

Overview
Date 2015 Apr 21
PMID 25893822
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We describe herein the unique case of a 70-year-old male with a TTF-1-positive non-adenomatous sellar tumor that has unusual morphological and immunohistochemical features. MRI examination detected a 2-cm sellar mass that was enhanced heterogeneously. By histology, the tumor was composed of epithelioid and oncocytic cells arranged in a trabecular pattern with occasional luminal structures. The lesion was diffusely immunopositive for thyroid transcription factor-1 (TTF-1) and vimentin but negative for S100 protein and GFAP. Immunoreactivity for epithelial membrane antigen, low molecular weight cytokeratin (CAM 5.2), and neuronal markers was also observed in the tumor cells. By electron microscopy, the tumor cells were filled with abundant mitochondria and extended microvillous projections into small extracellular and intracellular lumens. TTF-1 is considered to be an excellent marker of pituicytes, specialized glia of the neurohypophysis. This case can be regarded as a variant of pituicytoma, showing both ependymal differentiation and oncocytic changes. However, the immunoprofile was not completely consistent with a pituicyte lineage; the epithelial features suggested a possibility of folliculostellate cell origin. TTF-1-positive sellar neoplasms might therefore have variable morphological and immunohistochemical profiles. For suitable classification of TTF-1 positive sellar neoplasms, their histological features should be carefully re-evaluated.

Citing Articles

Posterior pituitary tumors and other rare entities involving the pituitary gland.

Roncaroli F, Giannini C Brain Pathol. 2024; 35(1):e13307.

PMID: 39350562 PMC: 11669417. DOI: 10.1111/bpa.13307.


Posterior pituitary tumours: patient outcomes and determinants of disease recurrence or persistence.

Das L, Vaiphei K, Rai A, Ahuja C, Singh P, Mohapatra I Endocr Connect. 2021; 10(4):387-400.

PMID: 33709954 PMC: 8142326. DOI: 10.1530/EC-20-0621.


A rare case report of pituicytoma with biphasic pattern and admixed with scattered Herring bodies.

Cao Y, Zeng Y, Qin X, Tan Y, Zeng M, Wang L World J Surg Oncol. 2020; 18(1):108.

PMID: 32460843 PMC: 7254636. DOI: 10.1186/s12957-020-01889-6.


A rare case of pituicytoma presenting with severe Cushing disease: A case report and review of literature.

Li X, Liu Y, Miao Y, Wang J, Wang L, Wang E Medicine (Baltimore). 2019; 98(44):e17772.

PMID: 31689841 PMC: 6946303. DOI: 10.1097/MD.0000000000017772.


Primary tumors of the posterior pituitary: A systematic review.

Guerrero-Perez F, Marengo A, Vidal N, Iglesias P, Villabona C Rev Endocr Metab Disord. 2019; 20(2):219-238.

PMID: 30864049 DOI: 10.1007/s11154-019-09484-1.